Almac has plans to further expand commercial manufacturing capabilities. Together with the recent completion of a new non-GMP drug development facility at the Craigavon site, this dual expansion represents a total investment of £13.7million, and the addition of 229 jobs during the next three years.   Almac’s existing facilities are at full capacity following the success of a laxative product contract manufactured by Almac. Almac plans to focus all production in Northern Ireland with additional e...